Patent · US Active

Modified nucleotides methods and kits

US10526652B2 · kind B2 · utility

0Cited by

22References

16Claims

0Family size

Assignee

Pierce Biotechnology, Inc. · US

Inventors

Christopher L. Etienne · Fitchburg, US
Kay Opperman · Oregon, US
Barbara J. Kaboord · Oregon, US
Scott Meier · Rockford, US
Jean-Samuel Schultz · Rockford, US

Key dates

Filing date	Oct 25, 2017
Grant date	Jan 7, 2020
Priority date	—
Expiry date	Dec 7, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y605/01003
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.